preclinical testing – Discover Pharma

Welcome to Discover Pharma! Today is : October 24, 2026

preclinical testing

Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development
Myomaker Bio launches lab-grown human muscle platform for preclinical drug testing
Myomaker Bio, a UK biotechnology company spun out from Loughborough [...]

May 5, 2026
Biotech & Pharma Business,Digital & Data,Drug Discovery & Development
FluoSphera raises €1.23 million to scale human-based preclinical testing platform
Swiss biotech startup FluoSphera has raised €1.23 million (CHF 1.15 [...]

May 5, 2026
Advanced Therapies,Clinical & Regulatory,Digital & Data
FDA shifts drug testing paradigm with plan to replace animal studies in monoclonal antibody development
Regulators back AI and organ-on-a-chip technologies to modernize safety evaluation [...]

May 5, 2026
Drug Discovery & Development
CN Bio expands liver-on-a-chip platform to include cross-species DILI models, enhancing IVIVE insights
CN Bio has introduced two new animal-derived liver-on-a-chip models to [...]

May 5, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK